ADAM17 as a Therapeutic Target in Multiple Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|20|2319-2335

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.20, 2009-07, pp. : 2319-2335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems

By  

Current Drug Targets, Vol. 16, Iss. 10, 2015-09 ,pp. : 1107-1132

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM33: a novel therapeutic target for asthma

By Powell Robert M   Hamilton Lynnsey M   Holgate Stephen T   Davies Donna E   Holloway John W  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 4, 2003-08 ,pp. : 485-494

Informa Healthcare

Access to resources Recommend Favorite

ADAM10 as a Therapeutic Target for Cancer and Inflammation

By  

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2288-2299

Bentham Science Publishers

Access to resources Recommend Favorite

Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases

By  

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1571-1596

Bentham Science Publishers

Access to resources Recommend Favorite